Clinical challenges in diagnosis and management of diabetic kidney disease.
Diabetic kidney disease (DKD) is a major and increasing worldwide public health issue. There is a great need for implementing treatments that either prevent or significantly slow the progression of DKD. Although there have been significant improvements in management, the increasing numbers of patients with DKD illustrate that current management is not wholly adequate. The reasons for suboptimal management include the lack of early diagnosis, lack of aggressive interventions, and lack of understanding about which interventions are most successful. There are a number of challenges and controversies regarding the current management of patients with DKD. Understanding of these issues is needed in order to provide the best care to patients with DKD. This article describes some of the clinically important challenges associated with DKD: the current epidemiology and cost burden and the role of biopsy in the diagnosis of DKD. Treatment controversies regarding current pharmacologic and nonpharmacologic approaches are reviewed and recommendations based on the published literature are made.
Kidney and Hypertension Division, Joslin Diabetes Center, Boston, MA. Electronic address: robert.stanton@joslin.harvard.edu.
Robert C
RC
Stanton
D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D017048:Health Care Costs; D006801:Humans; D015995:Prevalence; D011634:Public Health
Diabetic kidney disease (DKD); diabetes mellitus; prevalence; public health; renal disease